triazoles has been researched along with brimonidine tartrate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dick, HB; Krummenauer, F; Marx-Gross, S; Pfeiffer, N | 1 |
| Benelli, U; Canovetti, A; Figus, M; Fogagnolo, P; Nardi, M | 1 |
| Brown, S | 1 |
| Fraser, K | 1 |
1 trial(s) available for triazoles and brimonidine tartrate
| Article | Year |
|---|---|
Brimonidine versus dapiprazole: Influence on pupil size at various illumination levels.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Brimonidine Tartrate; Dark Adaptation; Diagnostic Techniques, Ophthalmological; Humans; Light; Ophthalmic Solutions; Piperazines; Prospective Studies; Pupil; Quinoxalines; Triazoles | 2005 |
3 other study(ies) available for triazoles and brimonidine tartrate
| Article | Year |
|---|---|
Aceclidine, brimonidine tartrate, and dapiprazole: comparison of miotic effect and tolerability under different lighting conditions.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Brimonidine Tartrate; Female; Humans; Light; Male; Middle Aged; Parasympatholytics; Piperazines; Prospective Studies; Pupil; Quinoxalines; Quinuclidines; Surveys and Questionnaires; Triazoles | 2009 |
Effectiveness of daily use of brimonidine as antimydriatic agent.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Brimonidine Tartrate; Humans; Light; Parasympatholytics; Piperazines; Pupil; Quinoxalines; Quinuclidines; Surveys and Questionnaires; Treatment Outcome; Triazoles | 2009 |
72nd annual meeting of the American Academy of Dermatology.
Topics: Antifungal Agents; Attention Deficit Disorder with Hyperactivity; Boron Compounds; Botulinum Toxins, Type A; Bridged Bicyclo Compounds, Heterocyclic; Brimonidine Tartrate; Depression; Dermatitis, Atopic; Food Hypersensitivity; Humans; Immunologic Factors; Ivermectin; Phosphodiesterase Inhibitors; Phototherapy; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Quinoxalines; Skin Diseases; Societies, Medical; Thalidomide; Triazoles; United States | 2014 |